IM Cannabis Corp

Chart & Performance

D1W1MN

P/E

—

P/S

0.01

EPS

—

Div Yield, %

—

Shrs. gr., 5y

1.91%

Rev. gr., 5y

28.06%

Revenues

55m

+1.30%

Net income

-11m

L+6.93%

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

IM Cannabis Corp. is engaged in the cultivation, processing, and supply of medical cannabis products across its operational territories of Israel, Germany, and Canada. The company's product portfolio features cannabis flowers and distinctive, strain-specific extracts marketed under its IMC brand. Additionally, it offers dried flower, pre-rolls, and pressed hash through its WAGNERS and Highland Grow labels. IM Cannabis Corp. caters to a diverse customer base, including medical patients and adult-use recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

URL

https://imcannabis.com/

IPO date

Oct 21, 1983

Employees

283

Domiciled in

Incorporated in

Valuation

Order:

Title CAD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CAD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2019‑04	2018‑12	2018‑04	2017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT